Back to Startups

Centivax

Bioscience & Disease Healthcare Systems

@Centivax Website LinkedIn San Francisco, California, USA

About Centivax

Privately held vaccine developer focused on creating innovative vaccine solutions, including a universal flu vaccine.

Business Information

Target Customers

healthcare providers government agencies pharmaceutical companies

Industry Categories

Bioscience & Disease Healthcare Systems

Business Model

Revenue Model B2B partnerships and government contracts

Pricing Strategy N/A

Sales Channels direct sales, partnerships with healthcare organizations

Funding Timeline

Round	Date	Amount	Investors
Series A	Jun 23, 2025	$45.0M	FutureWave Capital, NFX, Boldstartvc

Founders

No founder information available.

Investors

Recent Mentions

Adam Feuerstein ✡️ @adamfeuerstein

Jun 23, 2025

Per my colleague @ADeAngelis_bio Interesting tidbit, for the times we're in: Privately held vaccine developer Centivax has raised $45 million for a Series A round, STAT has learned. The company plans to begin its first clinical trial of a universal flu vaccine early next

View on Twitter

Raising.fi @raisingfi

Jul 08, 2025

New Raise 🏛️ Company: Centivax 🔗 Website: https://t.co/s6yTauEuzf 📊 Amount: $45 Million 🔄 Round: Series A 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter

SynBioBeta @SynBioBeta

Jul 09, 2025

Centivax Secures $45 Million Series A to Propel Universal Flu Vaccine into Clinical Trials. @centivax, a biotech firm focused on universal vaccines, has completed an oversubscribed $45 million Series A funding round led by Future Ventures, with participation from @NFX and BOLD https://t.co/vlxIYKaL0s

View on Twitter